BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,238 | +53.3% | 17,491 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $300,845 | +28.4% | 17,491 | +23.7% | 0.00% | 0.0% |
| Q1 2023 | $234,358 | +117.6% | 14,135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $107,709 | +7.7% | 14,135 | +40.0% | 0.00% | 0.0% |
| Q3 2022 | $100,000 | +8.7% | 10,097 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $92,000 | -9.8% | 10,097 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $102,000 | -44.0% | 10,097 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $182,000 | -51.7% | 10,935 | +36.1% | 0.00% | -50.0% |
| Q3 2021 | $377,000 | -23.1% | 8,035 | -0.1% | 0.00% | -33.3% |
| Q2 2021 | $490,000 | +59.1% | 8,045 | +61.1% | 0.00% | +50.0% |
| Q1 2021 | $308,000 | – | 4,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
| SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
| Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
| Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
| Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
| Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
| HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
| SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |